[{"Assets_0_Q3_USD":933746000.0,"CommonStockSharesOutstanding_0_Q3_shares":90673214.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":50910000.0,"NetIncomeLoss_1_Q3_USD":50764000.0,"NetIncomeLoss_3_Q3_USD":3033000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":96798000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":95272000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":90555000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":90064000.0,"StockholdersEquity_0_Q3_USD":447513000.0,"EarningsPerShareBasic_1_Q3_USD":0.56,"EarningsPerShareBasic_3_Q3_USD":0.03,"EarningsPerShareDiluted_1_Q3_USD":0.52,"EarningsPerShareDiluted_3_Q3_USD":0.03,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":151757000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":319748000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181105"}]